Patient‐derived organoid models help define personalized management of gastrointestinal cancer

E-ISSN： 1365-2168|105|2|e48-e60

ISSN： 0007-1323

Source： BRITISH JOURNAL OF SURGERY, Vol.105, Iss.2, 2018-01, pp. : e48-e60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?

By Jin Ketao He Kuifeng Li Guangliang Teng Lisong

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 597-606

Future Medicine

Access to resources Recommend Favorite

Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1121-1135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and validation of risk models and molecular diagnostics to permit personalized management of cancer

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1017-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite